IPQ Inside the global regulatory dialogue

Challenges of Implementing U.S. and Global Serialization Mandates Compel Industry Cooperation

Jan 23rd, 2016

Please Log in to print the full article

Marshall began the panel discussions with a review of DSCSA and how the requirements unfold through 2023. The act is Title II of the two-part Drug Quality and Safety Act (DQSA), passed by the U.S....

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications